APA (7th ed.) Citation

E, R., M, B., C, D., J, G., P, M., F, M., . . . J, S. (2023). [National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic DMARDS (disease modifying antirheumatic drugs)]. Zeitschrift fur Rheumatologie, 82(2), 163. https://doi.org/10.1007/s00393-022-01274-6

Chicago Style (17th ed.) Citation

E, Rath, et al. "[National Consensus Statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology Regarding the Management of Latent Tuberculosis and the Associated Utilization of Biologic and Targeted Synthetic DMARDS (disease Modifying Antirheumatic Drugs)]." Zeitschrift Fur Rheumatologie 82, no. 2 (2023): 163. https://doi.org/10.1007/s00393-022-01274-6.

MLA (9th ed.) Citation

E, Rath, et al. "[National Consensus Statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology Regarding the Management of Latent Tuberculosis and the Associated Utilization of Biologic and Targeted Synthetic DMARDS (disease Modifying Antirheumatic Drugs)]." Zeitschrift Fur Rheumatologie, vol. 82, no. 2, 2023, p. 163, https://doi.org/10.1007/s00393-022-01274-6.